600 Views

We experienced technical difficulties with capturing this session, so we are unable to make the session available for on-demand access. We apologize for the inconvenience.

Scientific Session

Oncology

Current and Prospective Cancer Immunotherapies

Thursday, June 23, 2022

11:15 AM – 12:15 PM CT

Location: ACC 5 ABC

CE: 1

Sponsored by

Primary Presenter(s)

Philip J. Bergman, DVM, MS, PhD, DACVIM (Oncology)

Director, Clinical Studies
VCA
Katonah, NY, New York, United States

Proceedings/Handout

This 50-60 minute lecture will review the latest and greatest veterinary oncology immunotherapeutics that are commercially available or provide a status on the pre-clinical development of other treatments. This lecture will also be done through the lens of the current status of similar cancer immunotherapeutics in physican-based oncology.

Learning Objectives:

Participant will become fluent in the currently commercially available veterinary oncology therapeutics
Participant will become aware of other extremely promising cancer immunotherapeutics in physician-based oncology
Participant will be become aware of those immunotherapeutics in veterinary oncology that are likely to become available in the near future